Article info
Letters
Antibodies to modified citrullinated vimentin are associated with severe extra-articular manifestations in rheumatoid arthritis
- Correspondence to
Dr Carl Turesson, Department of Rheumatology, Skåne University Hospital, Inga-Marie Nilssons gata 32, Malmö S-205 02, Sweden; Carl.Turesson{at}med.lu.se
Citation
Antibodies to modified citrullinated vimentin are associated with severe extra-articular manifestations in rheumatoid arthritis
Publication history
- Accepted May 12, 2013
- First published June 5, 2013.
Online issue publication
November 01, 2019
Article Versions
- Previous version (13 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions